Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Moritake

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Haematologica|August 29, 2015
Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemiaAtsushi Narita, Hideki Muramatsu, Yuko Sekiya, et al.
Leukemia|February 16, 2021
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndromeTakashi Taga, Shiro Tanaka, Daisuke Hasegawa, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2014
Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseasesNoriaki Kawano, Akira Tasaki, Takuro Kuriyama, et al.
Genes, Chromosomes & Cancer|January 8, 2017
ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosisGenki Yamato, Norio Shiba, Kenichi Yoshida, et al.
British Journal of Haematology|April 1, 2016
High event-free survival rate with minimum-dose-anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study GroupHiroyuki Takahashi, Tomoyuki Watanabe, Akitoshi Kinoshita, et al.
International Journal of Hematology|January 14, 2018
Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 studyAkira Shimada, Yuka Iijima-Yamashita, Akio Tawa, et al.
International Journal of Hematology|July 25, 2012
Acute myeloid leukemia in clinical practice: a retrospective population-based cohort study in Miyazaki Prefecture, JapanTakuya Matsunaga, Kiyoshi Yamashita, Yoko Kubuki, et al.
Japanese Journal of Ophthalmology|July 26, 2024
Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trialMitsuru Arima, Hirosuke Inoue, Akiko Misumi, et al.
Stem Cell Research & Therapy|June 26, 2019
Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34<sup>+</sup> cells using the auto-erasable Sendai virus vectorTakashi Okumura, Yumi Horie, Chen-Yi Lai, et al.
Haematologica|October 23, 2025
Age-specific mutation profiles and their prognostic implications in pediatric <i>KMT2A</i>-rearranged acute myeloid leukemiaKota Shoji, Kenichi Yoshida, Shinju Iyoda, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Haematologica|August 29, 2015
Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemiaAtsushi Narita, Hideki Muramatsu, Yuko Sekiya, et al.
Leukemia|February 16, 2021
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndromeTakashi Taga, Shiro Tanaka, Daisuke Hasegawa, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2014
Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseasesNoriaki Kawano, Akira Tasaki, Takuro Kuriyama, et al.
Genes, Chromosomes & Cancer|January 8, 2017
ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosisGenki Yamato, Norio Shiba, Kenichi Yoshida, et al.
British Journal of Haematology|April 1, 2016
High event-free survival rate with minimum-dose-anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study GroupHiroyuki Takahashi, Tomoyuki Watanabe, Akitoshi Kinoshita, et al.
International Journal of Hematology|January 14, 2018
Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 studyAkira Shimada, Yuka Iijima-Yamashita, Akio Tawa, et al.
International Journal of Hematology|July 25, 2012
Acute myeloid leukemia in clinical practice: a retrospective population-based cohort study in Miyazaki Prefecture, JapanTakuya Matsunaga, Kiyoshi Yamashita, Yoko Kubuki, et al.
Japanese Journal of Ophthalmology|July 26, 2024
Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trialMitsuru Arima, Hirosuke Inoue, Akiko Misumi, et al.
Stem Cell Research & Therapy|June 26, 2019
Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34<sup>+</sup> cells using the auto-erasable Sendai virus vectorTakashi Okumura, Yumi Horie, Chen-Yi Lai, et al.
Haematologica|October 23, 2025
Age-specific mutation profiles and their prognostic implications in pediatric <i>KMT2A</i>-rearranged acute myeloid leukemiaKota Shoji, Kenichi Yoshida, Shinju Iyoda, et al.
Pageof 12